147 related articles for article (PubMed ID: 23299779)
21. Association of IL-10 GTC haplotype with serum level and HPV infection in the development of cervical carcinoma.
Singhal P; Kumar A; Bharadwaj S; Hussain S; Bharadwaj M
Tumour Biol; 2015 Apr; 36(4):2287-98. PubMed ID: 25412954
[TBL] [Abstract][Full Text] [Related]
22. Cytokine gene polymorphisms and progression-free survival in classical Hodgkin lymphoma by EBV status: results from two independent cohorts.
Ghesquières H; Maurer MJ; Casasnovas O; Ansell SM; Larrabee BR; Lech-Maranda E; Novak AJ; Borrel AL; Slager SL; Brice P; Allmer C; Brion A; Ziesmer SC; Morschhauser F; Habermann TM; Gaillard I; Link BK; Stamatoullas A; Fermé C; Dogan A; Macon WR; Audouin J; Cerhan JR; Salles G
Cytokine; 2013 Nov; 64(2):523-31. PubMed ID: 24008079
[TBL] [Abstract][Full Text] [Related]
23. Interleukin 10 gene promoter polymorphisms (rs1800896, rs1800871 and rs1800872) and haplotypes are associated with the activity of systemic lupus erythematosus and IL10 levels in an Iranian population.
Mohammadi S; Saghaeian Jazi M; Zare Ebrahimabad M; Eghbalpour F; Abdolahi N; Tabarraei A; Yazdani Y
Int J Immunogenet; 2019 Feb; 46(1):20-30. PubMed ID: 30430731
[TBL] [Abstract][Full Text] [Related]
24. [Relationship of TGF-β and IL-4R gene polymorphisms with risk of classical Hodgkin lymphoma].
Wang XR; Li LZ; Huang T; Li H; Wang LQ; Li XX; Li FL
Zhonghua Xue Ye Xue Za Zhi; 2012 Dec; 33(12):1015-9. PubMed ID: 23363793
[TBL] [Abstract][Full Text] [Related]
25. Polymorphisms in IL-10 and TGF-β gene promoter are associated with lower risk to gastric cancer in a Mexican population.
Martínez-Campos C; Torres-Poveda K; Camorlinga-Ponce M; Flores-Luna L; Maldonado-Bernal C; Madrid-Marina V; Torres J
BMC Cancer; 2019 May; 19(1):453. PubMed ID: 31092242
[TBL] [Abstract][Full Text] [Related]
26. Association between TH2 Cytokine Gene Polymorphisms and Risk of Bullous Pemphigoid.
Tabatabaei-Panah PS; Moravvej H; Alirajab M; Etaaty A; Geranmayeh M; Hosseine F; Khansari A; Mahdian M; Mirhashemi M; Parvizi S; Sakhaie F; Ludwig RJ; Akbarzadeh R
Immunol Invest; 2022 Feb; 51(2):343-356. PubMed ID: 33047635
[TBL] [Abstract][Full Text] [Related]
27. Polymorphisms in the interleukin 10 gene promoter are associated with susceptibility to aggressive non-Hodgkin's lymphoma.
Cunningham LM; Chapman C; Dunstan R; Bell MC; Joske DJ
Leuk Lymphoma; 2003 Feb; 44(2):251-5. PubMed ID: 12688341
[TBL] [Abstract][Full Text] [Related]
28. Polymorphic variation in NFKB1 and other aspirin-related genes and risk of Hodgkin lymphoma.
Chang ET; Birmann BM; Kasperzyk JL; Conti DV; Kraft P; Ambinder RF; Zheng T; Mueller NE
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):976-86. PubMed ID: 19223558
[TBL] [Abstract][Full Text] [Related]
29. Polymorphisms in the promoter region of IL10 gene are associated with virus etiology of infant bronchiolitis.
Holster A; Teräsjärvi J; Vuononvirta J; Koponen P; Peltola V; Helminen M; He Q; Korppi M; Nuolivirta K
World J Pediatr; 2018 Dec; 14(6):594-600. PubMed ID: 29802545
[TBL] [Abstract][Full Text] [Related]
30. The effect of IL-10 genetic variation and interleukin 10 serum levels on Crohn's disease susceptibility in a New Zealand population.
Wang AH; Lam WJ; Han DY; Ding Y; Hu R; Fraser AG; Ferguson LR; Morgan AR
Hum Immunol; 2011 May; 72(5):431-5. PubMed ID: 21354456
[TBL] [Abstract][Full Text] [Related]
31. Cytokines Interleukin 4 (IL-4) and Interleukin 10 (IL-10) Gene Polymorphisms as Potential Host Susceptibility Factors in Virus-Induced Encephalitis.
Yu Y; Chen Y; Wang FL; Sun J; Li HJ; Liu JM
Med Sci Monit; 2017 Sep; 23():4541-4548. PubMed ID: 28935853
[TBL] [Abstract][Full Text] [Related]
32. Prognostic Significance of IL-6 in Hodgkin Lymphoma.
Bhethanabhotla S; Tiwari A; Sharma MC; Vishnubhatla S; Bakhshi S
Indian J Pediatr; 2019 Jun; 86(6):551-554. PubMed ID: 30830568
[TBL] [Abstract][Full Text] [Related]
33. Polymorphisms of interleukin 6 and interleukin 10 in Egyptian people with Behcet's disease.
Talaat RM; Ashour ME; Bassyouni IH; Raouf AA
Immunobiology; 2014 Aug; 219(8):573-82. PubMed ID: 24703990
[TBL] [Abstract][Full Text] [Related]
34. Association of IL10 and TGFB single nucleotide polymorphisms with intervertebral disc degeneration in Iranian population: a case control study.
Hanaei S; Abdollahzade S; Sadr M; Mirbolouk MH; Khoshnevisan A; Rezaei N
BMC Med Genet; 2018 Apr; 19(1):59. PubMed ID: 29636026
[TBL] [Abstract][Full Text] [Related]
35. Serum levels of interleukins 6, 10, and 13 before and after treatment of classic Hodgkin lymphoma.
Gaiolla RD; Domingues MA; Niéro-Melo L; de Oliveira DE
Arch Pathol Lab Med; 2011 Apr; 135(4):483-9. PubMed ID: 21466366
[TBL] [Abstract][Full Text] [Related]
36. Polymorphic variations in IL-1β, IL-6 and IL-10 genes, their circulating serum levels and breast cancer risk in Indian women.
Pooja S; Chaudhary P; Nayak LV; Rajender S; Saini KS; Deol D; Kumar S; Bid HK; Konwar R
Cytokine; 2012 Oct; 60(1):122-8. PubMed ID: 22818022
[TBL] [Abstract][Full Text] [Related]
37. Associations between genetic polymorphisms in
Hong P; Feng WY; Fu LH; Jin J; Fu JP
Cancer Biol Ther; 2020 Apr; 21(4):372-378. PubMed ID: 31910710
[No Abstract] [Full Text] [Related]
38. Interleukin-10 gene promoter region polymorphisms are not associated with BCG osteitis in vaccinated infants.
Pöyhönen L; Teräsjärvi J; Nuolivirta K; Vuononvirta J; Gröndahl-Yli-Hannuksela K; Kröger L; Huhtala H; Mertsola J; Ilonen J; Peltola V; Korppi M; He Q
Int J Tuberc Lung Dis; 2015 Oct; 19(10):1158-62. PubMed ID: 26459526
[TBL] [Abstract][Full Text] [Related]
39. Serum chemokine levels in Hodgkin lymphoma patients: highly increased levels of CCL17 and CCL22.
Niens M; Visser L; Nolte IM; van der Steege G; Diepstra A; Cordano P; Jarrett RF; Te Meerman GJ; Poppema S; van den Berg A
Br J Haematol; 2008 Mar; 140(5):527-36. PubMed ID: 18275430
[TBL] [Abstract][Full Text] [Related]
40. Genetic polymorphism of tumor necrosis factor promoter region and susceptibility to develop Hodgkin lymphoma in a Mexican population.
Torres-Espíndola LM; Velázquez-Cruz R; Falfán-Valencia R; Chavez-Pacheco JL; Salcedo-Vargas M; de Jesús Nambo-Lucio M; Salinas-Lara C; Alemón-Medina R; Granados-Montiel J; Reyes-Servín MA; Granados J; de Jesús Castillejos-López M
Leuk Lymphoma; 2014 Jun; 55(6):1295-9. PubMed ID: 24033107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
